Retractable Technologies (RVP) Liabilities and Shareholders Equity (2010 - 2026)
Retractable Technologies (RVP) posted Liabilities and Shareholders Equity of $137.6 million for Q1 2026, down 3.53% on a QoQ basis from $142.6 million in Q4 2025, and down 7.84% year-over-year from $149.3 million in Q1 2025.
Retractable Technologies (RVP) Liabilities and Shareholders Equity (2010 - 2026) Analysis & Trends
Retractable Technologies' Liabilities and Shareholders Equity history runs 17 years deep, the most recent figure standing at $137.6 million for Q1 2026.
- Quarterly Liabilities and Shareholders Equity fell 7.84% year-over-year to $137.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $573.8 million (down 8.72% YoY) and the FY2025 annual result came in at $142.6 million, down 11.26% from the prior year.
- Liabilities and Shareholders Equity was $137.6 million for Q1 2026 at Retractable Technologies, down from $142.6 million in the prior quarter.
- Across five years, Liabilities and Shareholders Equity topped out at $207.5 million in Q1 2022 and bottomed at $137.6 million in Q1 2026.
- A 5-year average of $171.6 million and a median of $176.0 million in 2024 frame the typical range for Liabilities and Shareholders Equity.
- Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity surged 49.89% — and 2025, when it declined 15.15%.
- Retractable Technologies' Liabilities and Shareholders Equity stood at $195.7 million in 2022, then declined by 8.17% to $179.7 million in 2023, then decreased by 10.55% to $160.7 million in 2024, then slipped by 11.26% to $142.6 million in 2025, then decreased by 3.53% to $137.6 million in 2026.
- Business Quant data shows RVP's Liabilities and Shareholders Equity at $137.6 million in Q1 2026, $142.6 million in Q4 2025, and $146.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 31.62 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 20.88 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 50.83 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 39.01 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 8.78 Bn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 4.08 Bn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 12.48 Bn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 14.10 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 6.31 Bn |
| 10 | Retractable Technologies | 20.36 Mn | -15.26 Mn | -838,408.00 | 137.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 137.60 Mn |
| Dec 31, 2025 | 142.63 Mn |
| Sep 30, 2025 | 146.43 Mn |
| Jun 30, 2025 | 147.09 Mn |
| Mar 31, 2025 | 149.31 Mn |
| Dec 31, 2024 | 160.72 Mn |
| Sep 30, 2024 | 157.81 Mn |
| Jun 30, 2024 | 160.74 Mn |
| Mar 31, 2024 | 175.98 Mn |
| Dec 31, 2023 | 179.67 Mn |
| Sep 30, 2023 | 181.52 Mn |
| Jun 30, 2023 | 186.77 Mn |
| Mar 31, 2023 | 193.66 Mn |
| Dec 31, 2022 | 195.67 Mn |
| Sep 30, 2022 | 200.58 Mn |
| Jun 30, 2022 | 194.28 Mn |
| Mar 31, 2022 | 207.50 Mn |
| Dec 31, 2021 | 206.30 Mn |
| Sep 30, 2021 | 177.99 Mn |
| Jun 30, 2021 | 175.70 Mn |